AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neuhaus, F. C.
Right arrow Articles by Neuhaus, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neuhaus, F. C.
Right arrow Articles by Neuhaus, D. W.

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1977 April; 11(4): 638-644
Copyright © 1977 American Society for Microbiology. All Rights Reserved.

Growth Inhibition of Escherichia coli W by D-Norvalyl-D-Alanine: an Analogue of D-Alanine in Position 4 of the Peptide Subunit of Peptidoglycan

F. C. Neuhaus, S. Goyer and D. W. Neuhaus

1 Department of Biochemistry and Molecular Biology, Northwestern University, Evanston, Illinois 60201

ABSTRACT

Position 4 analogues of D-alanine in the peptide subunit of uridine 5'-diphosphate-N-acetylmuramyl-Ala1-DGlu2- Lys3-DAla4-DAla5 have a significant inhibitory effect on penicillin-sensitive peptidoglycan synthesis in Gaffkya homari (C. V. Carpenter, S. Goyer, and F. C. Neuhaus, 1976). The specificity profile of this in vitro system has been used as a basis for designing analogues with potential antibacterial activity. To circumvent the specificity determinants exerted by D-alanine:D-alanine ligase (adenosine 5'-diphosphate), attention was directed to DD-dipeptides of the type D-alanyl-analogue-D-alanine as a method for incorporating analogues into position 4 of the peptide subunit in vivo. Of the three dipeptides, DAbu-DAla, DNva-DAla, and DVal-DAla, only DNva-DAla (5 x 10–4 M) inhibited the growth of Escherichia coli W in the presence of 5 x 10–6 M D-cycloserine. This concentration of D-cycloserine did not inhibit growth, but it potentiated the bactericidal activity of the dipeptide. The lack of antibacterial activity observed with DAbu-DAla and DVal-DAla was correlated with the poor ability of these dipeptides to be taken up via the dipeptide transport system of this organism. Prevention of lysis induced by DNva-DAla plus D-cycloserine by certain dipeptides and not by others supported this correlation. It is proposed that the D-norvalyl residue of the dipeptide is incorporated in vivo into position 4 of the peptide subunit of peptidoglycan, and that this subunit is not an effective substrate in the reaction(s) catalyzed by the penicillin-susceptible enzyme(s) of cross-linked peptidoglycan synthesis.


Antimicrob Agents Chemother. 1977 April; 11(4): 638-644
Copyright © 1977 American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 1977 by the American Society for Microbiology. All rights reserved.